Vector Models and Indexing for Small Molecule Drug

Data Characteristics

Small molecule drug registration dossiers primarily include pharmaceutical research data (e.g., synthesis processes, quality standards, stability studies), pharmacology and toxicology research data (e.g., pharmacodynamics, toxicokinetics), and clinical research data (e.g., clinical protocols, trial reports). Data sources mainly consist of internal R&D documents, CRO reports, and public regulatory guidelines and regulations. Document structures are highly standardized, often adhering to ICH M4E or NMPA format requirements. These documents contain large amounts of structured or semi-structured data, such as reaction equations, chemical structures, spectra, and tables (e.g., batch analysis data, stability study data). Field units are precise, such as μg/mL, mg/kg, kPa, ℃, and often accompanied by specific detection methods and instrument information. The data update frequency is relatively low, primarily concentrated at key milestones during the R&D phase and during regulatory review feedback.

Constraints Imposed by These Characteristics on Vector Models and Indexing

The standardized nature of small molecule drug data means document chunking should prioritize semantic completeness. Avoid breaking the context of critical tables or paragraphs. For example, compound synthesis steps, detailed quality standards, and clinical trial designs should be indexed as relatively independent semantic units. The extensive use of specialized terminology, compound names, and experimental data demands high vocabulary understanding and numerical representation capabilities from vector models. Generic models may struggle to accurately capture deep meanings. The low update frequency allows for a relaxed vector index reconstruction cycle. However, each update must ensure the integrity of incremental data. Reliance on structured information requires vector models to effectively encode tables, spectra, and other information, or to enhance retrieval with metadata indexing. The precision of units and values directly impacts the accuracy of recall results. Avoid numerical misinterpretations caused by vector similarity.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`Chunk size` (Chunk Size)	`500–800 characters` (characters)	Ensures the completeness of key semantic units like chemical synthesis steps and detailed quality standards, preventing over-chunking.
`Chunk overlap` (Chunk Overlap)	`50–100 characters` (characters)	Maintains contextual coherence, especially in cross-paragraph references, ensuring the recall of important information.
`embedding_model`	`bge-m3` or `text-embedding-v3`	Possesses multilingual and cross-domain understanding capabilities, with good encoding performance for biomedical professional terminology.
`Recall count` (Recall Count)	`8–15 entries` (items)	Balances retrieval efficiency and coverage, especially when dealing with complex submission documents, increasing the recall of potentially related information.
`Similarity threshold` (Similarity Threshold)	Calibrate based on actual measurements, recommended `0.75–0.85`	Ensures the relevance of recall results, preventing interference from low-relevance documents. Adjustment based on actual data is necessary.
`Rerank result count` (Rerank Return Count)	`3–5 entries` (items)	Further refines results based on initial recall, focusing on the most relevant key snippets.

Common Pitfalls

Query results lack critical experimental data tables or chemical structures. This usually happens when Chunk size (Chunk Size) is set too small, causing the context containing tables or structural diagrams to be improperly chunked.
When retrieving synthesis steps for a specific drug, the returned snippets contain a large amount of irrelevant pharmacology and toxicology content. This may be due to a Similarity threshold (Similarity Threshold) set too low or an embedding_model with insufficient differentiation for specialized terminology.
After integrating a custom vector model, the Knowledge Base status shows "Vectorization failed" or "Index building timed out." This is often because the PARSE_FILE_TIMEOUT_SECONDS parameter is too short to process large PDFs or documents with complex charts, or because of incorrect embedding_model interface configuration leading to call failures.

How to Verify Configuration

Select several representative small molecule drug registration dossiers. Manually chunk key semantic paragraphs and compare them with the system's automatic chunking results. Verify if Chunk size (Chunk Size) and Chunk overlap (Chunk Overlap) are reasonable.
Ask questions about specific compound names, key experimental methods, or regulatory terms. Check if the recall results include the expected original document snippets and relevant data.
Select several documents containing non-textual information like tables and spectra. Verify their vectorization and retrieval effectiveness to ensure this information is effectively indexed and recalled.
Evaluate the Recall count (Recall Count) and Rerank result count (Rerank Return Count) under different queries. Observe the relevance and diversity of the results, and adjust the Similarity threshold (Similarity Threshold) as needed.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.